Our research into lymphoma
Our strategy
For the past 120 years, we’ve been making discoveries that have saved countless lives. But we have so much more to do. Our strategy sets out how we'll accelerate progress towards a better future.
Our research is saving lives
There are more than 30 types of lymphoma, grouped into Hodgkin and non-Hodgkin lymphoma. In the 1970s almost half of people diagnosed with Hodgkin lymphoma survived their disease beyond 10 years, now it's 8 in 10. And for non-Hodgkin lymphoma, survival has tripled in the last 40 years in the UK. We’ve made good progress in many forms of the disease, but there’s still much more to do.
Current research
From studying the biology of lymphoma cells in the lab to leading clinical trials testing cutting-edge treatments, our researchers are working hard to ensure more people survive lymphoma.
Past research
Thanks to research, we’ve helped change the outlook for people with lymphoma.
Patients' stories
Meet people like Rajvinder who have experienced first-hand how our research is making a difference. The life-saving research we do wouldn’t be possible without your support.
Cancer news
From cutting edge science and debunking myths to patient stories, read the latest news, analysis and opinion on our news site.
Further information
Our strategy
Over the last 40 years, cancer survival in the UK has doubled. In the 1970s just 1 in 4 people survived their disease for 10 years or more. Today 2 in 4 survive.
We want to accelerate progress and see 3 in 4 patients surviving the disease by 2034.